Banca de QUALIFICAÇÃO: HARYELLE NARYMA CONFESSOR FERREIRA

Uma banca de QUALIFICAÇÃO de DOUTORADO foi cadastrada pelo programa.
STUDENT : HARYELLE NARYMA CONFESSOR FERREIRA
DATE: 20/09/2024
TIME: 15:00
LOCAL: REMOTO-VIDEOCONFERÊNCIA
TITLE:

EVALUATION OF HOSPITAL MORBIDITY AND MORTALITY DUE TO BREAST AND UTERINE CANCER IN WOMEN IN BRAZIL BETWEEN 2010 AND 2022

KEY WORDS:

Epidemiology. Cervical cancer. Breast cancer. Health inequalities.

PAGES: 70
BIG AREA: Ciências da Saúde
AREA: Saúde Coletiva
SUMMARY:

Breast and cervical cancer are a serious public health problem worldwide. Early screening, identification and treatment are generally the most widely used means of reducing mortality. In Brazil, difficulties in accessing the public health system lead to diagnoses at more advanced stages of cancer and therefore require more aggressive therapeutic approaches that can result in functional, emotional and social sequelae. This study aims to evaluate hospital mortality and morbidity from breast and uterine cancer in relation to Brazilian regions between 2010 and 2022. This is an ecological time series study from 2010 to 2022 using data on hospital admissions and deaths, both in the public domain and stored in the Ministry of Health's DATASUS. The results show that between 2010 and 2022, mammography rates ranged from 36 to 71 exams, while Pap smear rates ranged from 126 to 226 cytopathological exams per 1,000 women. Hospitalizations for these types of cancer peaked in 2019, with 48 hospitalizations for cervical cancer per 100,000 women and 147 hospitalizations for breast cancer for the same population. For both, in the years of the pandemic, between 2020 and 2022, there is a decrease in Brazil and in all its regions. With regard to screening for these diseases, it was observed that the number of mammograms and preventive exams showed similar behavior, with a greater supply of these exams until 2019 and a drop during the pandemic period. The geographical educational limitations of each region hinder access to diagnosis and appropriate treatment. It is worth noting that the number of deaths from breast and uterine cancer in Brazil and its regions increased significantly over the same period (2010-2022). We believe it is important to rethink the priorities in clinical practice and management of the SUS, considering the work process beyond the discussion of therapeutic improvement strategies, but also including the biopsychosocial aspects of women with breast and uterine cancer in the local context, in order to guarantee equity and integrality in health care. This leads to the conclusion that although Brazil has several policies for screening for these diseases, there is still instability in the supply of these tests, reinforcing the weaknesses of the care network and the changes needed in the organization and quality of the services provided.

COMMITTEE MEMBERS:
Presidente - 1879353 - FABIA BARBOSA DE ANDRADE
Interna - 2374850 - THAIZA TEIXEIRA XAVIER NOBRE
Externo à Instituição - CINTIA BEZERRA ALMEIDA COSTA - UFPB